Skip to search formSkip to main contentSkip to account menu

RPMI-8226

A lymphoblast-like cell line established from the peripheral blood of a 61 year old male patient with multiple myeloma (IgG lambda-type).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Objective:  Activation of PPARγ by its ligands has shown potential anti‐neoplastic effects in solid tumors. In this study, we… 
Highly Cited
2008
Highly Cited
2008
Bisphosphonates (BPs) are effective inhibitors of tumor-induced bone resorption. Recent studies have demonstrated that BPs… 
Highly Cited
2003
Highly Cited
2003
Bisphosphonates have recently been introduced in the therapeutic armamentarium for long-term treatment of patients with multiple… 
Highly Cited
2002
Highly Cited
2002
TALL‐1 is a member of the tumor necrosis factor family that binds to BCMA, TACI, and BAFF‐R, three receptors mostly expressed by… 
1999
1999
Peripheral blood T cells from a patient with multiple myeloma in complete remission were selected in vitro against an autologous…